The SEC's 2025 guidance aims to bring clarity and a more structured regulatory framework to the digital asset space.

Travelers Companies TRV has outperformed the market over the past 5 years by 4.07% on an annualized basis producing an average annual return of 17.0%. Currently, Travelers Companies has a market capitalization of $61.76 billion.

U.S. stocks traded lower this morning, with the Dow Jones index falling over 300 points on Monday. Following the market opening Monday, the Dow traded down 0.72% to 41,967.43 while the NASDAQ fell 0.38% to 19,040.92. The S&P 500 also fell, dropping, 0.58% to 5,877.58.

VivoPower to leverage BitGo's best-in-class OTC trading desk and custody platform to build digital asset treasury strategy ...

Rivian dips after unveiling $1.25B green notes offering to refinance 2026 debt with 2031 notes Despite solid cash and growth plans, Rivian trims 2025 delivery outlook amid tariff uncertainty Get access to the leaderboards pointing to tomorrow's biggest stock movers.

SAIC Q1 sales beat estimates, but EPS missed. SAIC keeps full-year outlook below expectations as margins shrink and cash flow turns negative. Rebound or breakdown? See how Matt Maley is trading June's market volatility, live this Wednesday, June 4 at 6 PM ET.

In a space moving at the speed of light, the difference between a forgotten token and a billion-dollar project comes down to this: how well you control your narrative, community, and visibility. Here's how award-winning web3 media agency CredibilityX helps serious projects stand out and succeed.

Guardian acquires Mercury Pharmacy to expand into Washington's growing LTC market. Deal adds Seattle-Tacoma coverage and keeps existing staff in place. Get access to the leaderboards pointing to tomorrow's biggest stock movers. Guardian Pharmacy Services, Inc.

KT-621 achieved >95% STAT6 degradation in blood and skin at doses ≥50 mg. Median TARC biomarker reduction of 37% observed by Day 14 across dose groups. Get access to the leaderboards pointing to tomorrow's biggest stock movers. Kymera Therapeutics, Inc.

NEWTON, Mass., June 02, 2025 ( GLOBE NEWSWIRE ) -- 4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, unveiled groundbreaking findings at the American Society of Clinical Oncology ( ASCO ) 2025 Annual Meeting, revealing the ...